GSTM3 / Glutathione S-transferase Mu 3 · Western blot design guide

Design a Western Blot for GSTM3

Real validated GSTM3 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GSTM3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for GSTM3: expected band ~26.6 kDa, hero antibody A03298-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable GSTM3 Western blot protocol sheet — expected band ~26.6 kDa, antibody A03298-1, controls and PMC citations. Open the full GSTM3 WB guide →

GSTM3 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~26.6 kDa
Observed band ~27 kDa
Gel 12% (catalog A03298-1)
Positive control ⓘ Kidney (IHC candidate; verify WB) +3 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Ubl conjugation
Caveat Modification-state controls
Gene-set association MSigDB Hallmark membership
Isoform 1 isoform(s)
Section 1

Real Curated GSTM3 Western Blot Protocols

The A03298-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman Hela, human MCF-7, human SiHa (catalog A03298-1)
Gel %12% (catalog A03298-1)
Load30 ug; reducing conditions (catalog A03298-1)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A03298-1)
Membranenitrocellulose membrane (catalog A03298-1)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A03298-1)
Primary antibodyA03298-1 · 0.5 μg/mL (catalog A03298-1)
Primary incubationovernight at 4°C (catalog A03298-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A03298-1)
Secondary incubation1.5 hour at RT (catalog A03298-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A03298-1)
DetectionECL (catalog A03298-1)
Section 2

What Is the Expected GSTM3 Western Blot Band Size?

GSTM3 is predicted at 26.6 kDa and observed near 27 kDa under reducing conditions; the small difference has no established cause in the supplied evidence.

What am I looking at on my blot?
Single band near 27 kDaGSTM3 monomer, consistent with the empirical reducing-condition band
Band near 53 kDapossible retained GSTM3 homodimer; confirm its identity
Bands near 27 and 53 kDapossible monomer and retained homodimer; confirm both bands
27 kDa band with no 53 kDa bandconsistent with dissociation of the homodimer during SDS-PAGE
💡Expected GSTM3 appearanceUniProt predicts a 26.6 kDa monomer, and antibody QC shows a band at approximately 27 kDa under reducing conditions; confirm band identity with appropriate controls.
How each factor affects band size
Predicted monomer mass26.6 kDa from UniProt, consistent with the observed band near 27 kDa
225-residue protein sequenceunderlies the predicted 26.6 kDa monomer mass
Homodimer formationcould produce a band near twice the monomer mass if the dimer survives electrophoresis
Homodimer dissociation during SDS-PAGEfavors the monomer band near 27 kDa
Why is my band missing or off?
SituationLikely causeNext action
No band in lysatecytoplasmic GSTM3 may be below detection in the loaded samplecheck lysate loading and include a GSTM3-positive control
Band higher than expecteda GSTM3 homodimer may have survived electrophoresiscompare denaturing conditions and verify band identity
Band lower than expectedidentity or sample integrity is uncertain; no cleavage feature is listedcheck sample handling and verify the band with an independent antibody
Multiple bandspossible monomer and retained homodimer, or nonspecific signalscompare denaturing conditions and use a GSTM3-specific control
Weak or no signalinsufficient detectable cytoplasmic GSTM3 or antibody signalcheck loading, transfer, and a positive-control lysate

Sample controls for GSTM3 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for GSTM3 in Western blot, you can use kidney lysate, which shows high HPA expression.
Positive control: Kidney (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: Cytoplasmic localization and an HPA not-detected tissue make lysate controls feasible.

HPA tissue expression evidence for GSTM3

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Kidney distal tubules High Protein (IHC) HPA →
Epididymis glandular cells Medium Protein (IHC) HPA →
Seminal vesicle glandular cells Medium Protein (IHC) HPA →
Testis elongated or late spermatids Medium Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Adrenal gland glandular cells Not detected Protein (IHC) HPA →
Appendix glandular cells Not detected Protein (IHC) HPA →
Bone marrow hematopoietic cells Not detected Protein (IHC) HPA →
Breast adipocytes Not detected Protein (IHC) HPA →
Section 3

Advanced GSTM3 Western Blot Tips

Deeper troubleshooting and optimisation questions for GSTM3, answered from its protein features.

How should GSTM3 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Could a second band represent a GSTM3 isoform?
Isoforms · The supplied record lists one isoform and no alternative sequence. These features do not support assigning a second band to a documented GSTM3 isoform.
Do GSTM3 modifications explain a shifted band?
PTM · The record includes Ubl conjugation and isopeptide bond keywords but lists no modified-residue coordinates. Those keywords alone do not establish a visible shift or identify a particular shifted band.
Does this guide establish induction of GSTM3?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for GSTM3?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A03298-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
Which band should be quantified for GSTM3?
Quantitation · Quantify a consistently identified band near the observed 27 kDa position. The predicted mass is 26.6 kDa; the supplied features do not establish that other bands are GSTM3.
How does the observed band compare with GSTM3’s predicted mass?
Interpretation · The observed band is approximately 27 kDa, close to the predicted 26.6 kDa for the 225-residue protein. This small difference does not require a band-shift explanation.

GSTM3 is annotated as a homodimer. If a higher band appears, consider that property during interpretation, but the annotation alone does not show that the band is a dimer.

Use the approximately 27 kDa observed band and 26.6 kDa predicted mass as reference points. The record lists one isoform and identifies GSTM3 as a homodimer, but neither feature alone assigns an unexpected band. Its cytoplasmic location may also help assess whether the sample fraction is appropriate.
Boster reagents

GSTM3 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of GSTM3 using anti-GSTM3 antibody (A03298-1). Electrophoresis was performed on a 12% SDS-PAGE gel at 80V (Stacking gel) / 120V (Resolving gel) for 2 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human Hela whole cell lysates, Lane 2: human MCF-7 whole cell lysates, Lane 3: human SiHa whole cell lysates, Lane 4: human THP-1 whole cell lysates, Lane 5: mouse testis tissue lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-GSTM3 antigen affinity purified polyclonal antibody (A03298-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an ECL Plus Western Blotting Substrate (Catalog # AR1196-200) with Tanon 5200 system. A specific band was detected for GSTM3 at approximately 27 kDa. The expected band size for GSTM3 is at 27 kDa.
Anti-GSTM3 Antibody Picoband®
Cat # A03298-1

The catalog reports one anti-GSTM3 antibody for Western blot, A03298-1, with reported human and mouse reactivity. Its product blot reports a band at approximately 27 kDa using human cell and mouse testis lysates. No independent publication evidence is supplied.

Which to pick: A03298-1 is the only listed option and has a WB image. The documented samples are HeLa, MCF-7, SiHa and THP-1 whole-cell lysates, plus mouse testis lysate; these examples do not establish validation across all human or mouse samples.

Source: BosterBio GSTM3 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.